348 related articles for article (PubMed ID: 31315786)
21. A repository of microbial marker genes related to human health and diseases for host phenotype prediction using microbiome data.
Han W; Ye Y
Pac Symp Biocomput; 2019; 24():236-247. PubMed ID: 30864326
[TBL] [Abstract][Full Text] [Related]
22. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.
Yi M; Jiao D; Qin S; Chu Q; Li A; Wu K
Integr Cancer Ther; 2019; 18():1534735419876351. PubMed ID: 31517538
[TBL] [Abstract][Full Text] [Related]
23. Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients.
Gately S
Cancer Treat Res; 2019; 178():253-264. PubMed ID: 31209849
[TBL] [Abstract][Full Text] [Related]
24. The Microbiome-Immune Axis Therapeutic Effects in Cancer Treatments.
Son YM; Kim J
J Microbiol Biotechnol; 2022 Sep; 32(9):1086-1097. PubMed ID: 36116940
[TBL] [Abstract][Full Text] [Related]
25. The microbiome and cancer for clinicians.
Picardo SL; Coburn B; Hansen AR
Crit Rev Oncol Hematol; 2019 Sep; 141():1-12. PubMed ID: 31202124
[TBL] [Abstract][Full Text] [Related]
26. Exploring the role of respiratory microbiome in lung cancer: A systematic review.
Perrone F; Belluomini L; Mazzotta M; Bianconi M; Di Noia V; Meacci F; Montrone M; Pignataro D; Prelaj A; Rinaldi S; Russano M; Sartori G; Bironzo P; Facchinetti F; Menis J; Tiseo M; Galetta D; Novello S; Pilotto S
Crit Rev Oncol Hematol; 2021 Aug; 164():103404. PubMed ID: 34214609
[TBL] [Abstract][Full Text] [Related]
27. The potential impact of gut microbiota on your health:Current status and future challenges.
Sirisinha S
Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
[TBL] [Abstract][Full Text] [Related]
28. Impact of the microbiome on checkpoint inhibitor treatment in patients with non-small cell lung cancer and melanoma.
Shaikh FY; Gills JJ; Sears CL
EBioMedicine; 2019 Oct; 48():642-647. PubMed ID: 31597596
[TBL] [Abstract][Full Text] [Related]
29. A pan-cancer analysis of the microbiome in metastatic cancer.
Battaglia TW; Mimpen IL; Traets JJH; van Hoeck A; Zeverijn LJ; Geurts BS; de Wit GF; Noë M; Hofland I; Vos JL; Cornelissen S; Alkemade M; Broeks A; Zuur CL; Cuppen E; Wessels L; van de Haar J; Voest E
Cell; 2024 Apr; 187(9):2324-2335.e19. PubMed ID: 38599211
[TBL] [Abstract][Full Text] [Related]
30. The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?
Hekmatshoar Y; Rahbar Saadat Y; Hosseiniyan Khatibi SM; Ozkan T; Zununi Vahed F; Nariman-Saleh-Fam Z; Pourghassem Gargari B; Sunguroglu A; Zununi Vahed S
Life Sci; 2019 Sep; 233():116680. PubMed ID: 31344431
[TBL] [Abstract][Full Text] [Related]
31. [Preface for special issue on microbiome and human health].
Wang J; Wang J; Deng Z
Sheng Wu Gong Cheng Xue Bao; 2021 Nov; 37(11):3711-3716. PubMed ID: 34841778
[TBL] [Abstract][Full Text] [Related]
32. Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms.
Xu N; Wang L; Li C; Ding C; Li C; Fan W; Cheng C; Gu B
Transl Lung Cancer Res; 2020 Aug; 9(4):1554-1568. PubMed ID: 32953527
[TBL] [Abstract][Full Text] [Related]
33. The human gut microbiome as source of innovation for health: Which physiological and therapeutic outcomes could we expect?
Doré J; Multon MC; Béhier JM;
Therapie; 2017 Feb; 72(1):21-38. PubMed ID: 28131442
[TBL] [Abstract][Full Text] [Related]
34. Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome.
Pitt JM; Vétizou M; Waldschmitt N; Kroemer G; Chamaillard M; Boneca IG; Zitvogel L
Cancer Res; 2016 Aug; 76(16):4602-7. PubMed ID: 27474734
[TBL] [Abstract][Full Text] [Related]
35. Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential.
Saus E; Iraola-Guzmán S; Willis JR; Brunet-Vega A; Gabaldón T
Mol Aspects Med; 2019 Oct; 69():93-106. PubMed ID: 31082399
[TBL] [Abstract][Full Text] [Related]
36. Microbiome dysbiosis in lung cancer: from composition to therapy.
Liu NN; Ma Q; Ge Y; Yi CX; Wei LQ; Tan JC; Chu Q; Li JQ; Zhang P; Wang H
NPJ Precis Oncol; 2020 Dec; 4(1):33. PubMed ID: 33303906
[TBL] [Abstract][Full Text] [Related]
37. Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets.
Dai JH; Tan XR; Qiao H; Liu N
Protein Cell; 2024 Apr; 15(4):239-260. PubMed ID: 37946397
[TBL] [Abstract][Full Text] [Related]
38. Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?
Villéger R; Lopès A; Carrier G; Veziant J; Billard E; Barnich N; Gagnière J; Vazeille E; Bonnet M
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31533218
[TBL] [Abstract][Full Text] [Related]
39. Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects.
Liu HX; Tao LL; Zhang J; Zhu YG; Zheng Y; Liu D; Zhou M; Ke H; Shi MM; Qu JM
Int J Cancer; 2018 Feb; 142(4):769-778. PubMed ID: 29023689
[TBL] [Abstract][Full Text] [Related]
40. [Intestinal microbiom modulates the response to antitumor immunotherapy].
Olekhnovich EI; Manolov AI; Pavlenko AV; Konanov DN; Fedorov DE; Tikhonova PO; Glushchenko OE; Ilina EN
Biomed Khim; 2020 Jan; 66(1):54-63. PubMed ID: 32116226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
